Hypertension: Causes, Risk Factors, Prevention, and Management Essentials

Hypertension (HTN) – persistently elevated blood pressure ≥130/80 mmHg (ACC/AHA) or ≥140/90 mmHg (ESC/WHO) – affects ~1.3 billion adults globally. It is the leading modifiable risk factor for cardiovascular death.

Etiology and Risk Factors

Non-Modifiable

  • Genetics: Heritability ~30–50%; polygenic (ACE, AGT, ADD1 variants). Family history doubles risk.
  • Age: Prevalence >60% at age >60; arterial stiffening, reduced compliance.
  • Race/ethnicity: Black adults: earlier onset, greater severity, higher salt sensitivity, lower renin.
  • Sex: Men > women until ~65; postmenopausal women catch up (loss of estrogen protection).

Modifiable

  • Obesity/overweight: BMI ≥25; visceral adiposity → RAAS activation, SNS overactivity, insulin resistance.
  • High sodium / low potassium intake: Sodium >2.3 g/day; potassium <3.5 g/day.
  • Physical inactivity: <150 min/week moderate activity.
  • Alcohol excess: >2 drinks/day (men), >1 (women).
  • Smoking/vaping: Acute BP elevation; endothelial dysfunction.
  • Psychosocial stress: Chronic stress → cortisol, SNS dysregulation.
  • Sleep disorders: OSA (major secondary cause), short sleep duration.

Secondary Causes (5–10% of cases)

  • Renal: CKD, renal artery stenosis, glomerulonephritis.
  • Endocrine: Primary aldosteronism (5–10% of HTN), Cushing's, pheochromocytoma, thyroid disease, hyperparathyroidism.
  • Vascular: Coarctation of aorta.
  • Drug-induced: NSAIDs, oral contraceptives, steroids, stimulants, decongestants, immunosuppressants, antidepressants (SNRIs).

Prevention Strategies

  • DASH diet: Fruits, vegetables, whole grains, low-fat dairy, nuts, legumes; limits sodium, saturated fat, sugar.
  • Sodium reduction: Target <1.5–2.3 g/day; greatest benefit in salt-sensitive individuals.
  • Weight loss: 1 kg loss ≈ 1 mmHg BP reduction.
  • Regular exercise: Aerobic 150 min/week + resistance 2×/week → ↓5–8 mmHg SBP.
  • Moderate alcohol: ≤2 drinks/day (men), ≤1 (women).
  • Smoking cessation.
  • Stress management: Mindfulness, CBT, adequate sleep.

Diagnosis and Monitoring

  • Out-of-office BP (home/ambulatory) preferred for diagnosis – avoids white-coat/masked HTN.
  • Proper technique: seated 5 min, supported back/feet/arm, validated device, average ≥2 readings.
  • Screen for target organ damage: ECG, echo, retinal exam, UACR, eGFR, electrolytes, lipids, glucose.

Treatment Overview

  • Lifestyle first for stage 1 (130–139/80–89) without ASCVD/high risk.
  • First-line meds: ACEi/ARB, CCB, thiazide/thiazide-like diuretic.
  • Compelling indications: ACEi/ARB for diabetes, CKD, HFrEF; CCB for isolated systolic HTN in elderly; beta-blockers for post-MI, HF.
  • Target: <130/80 for most; individualized for frail elderly, orthostatic hypotension.

Hypertension is a silent killer. Regular screening, early intervention, and sustained control prevent millions of strokes, heart attacks, and kidney failures annually.

Hypertension - Related Articles